Viewing Study NCT00728520

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2026-05-16 @ 7:52 PM
Study NCT ID: NCT00728520
Status: UNKNOWN
Last Update Posted: 2008-08-06
First Post: 2008-07-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
Sponsor: Kansas City Veteran Affairs Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Elderly View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Azacitidine View
None Untreated View
None Elderly View